812 related articles for article (PubMed ID: 27631143)
1. Behavioral Effects of Neurofeedback Compared to Stimulants and Physical Activity in Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial.
Geladé K; Janssen TW; Bink M; van Mourik R; Maras A; Oosterlaan J
J Clin Psychiatry; 2016 Oct; 77(10):e1270-e1277. PubMed ID: 27631143
[TBL] [Abstract][Full Text] [Related]
2. A Randomized Controlled Trial Investigating the Effects of Neurofeedback, Methylphenidate, and Physical Activity on Event-Related Potentials in Children with Attention-Deficit/Hyperactivity Disorder.
Janssen TW; Bink M; Geladé K; van Mourik R; Maras A; Oosterlaan J
J Child Adolesc Psychopharmacol; 2016 May; 26(4):344-53. PubMed ID: 26771913
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial into the effects of neurofeedback, methylphenidate, and physical activity on EEG power spectra in children with ADHD.
Janssen TW; Bink M; Geladé K; van Mourik R; Maras A; Oosterlaan J
J Child Psychol Psychiatry; 2016 May; 57(5):633-44. PubMed ID: 26748531
[TBL] [Abstract][Full Text] [Related]
4. An RCT into the effects of neurofeedback on neurocognitive functioning compared to stimulant medication and physical activity in children with ADHD.
Geladé K; Bink M; Janssen TW; van Mourik R; Maras A; Oosterlaan J
Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):457-468. PubMed ID: 27665293
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive effects of neurofeedback in adolescents with ADHD: a randomized controlled trial.
Bink M; van Nieuwenhuizen C; Popma A; Bongers IL; van Boxtel GJ
J Clin Psychiatry; 2014 May; 75(5):535-42. PubMed ID: 24922488
[TBL] [Abstract][Full Text] [Related]
6. A 6-month follow-up of an RCT on behavioral and neurocognitive effects of neurofeedback in children with ADHD.
Geladé K; Janssen TWP; Bink M; Twisk JWR; van Mourik R; Maras A; Oosterlaan J
Eur Child Adolesc Psychiatry; 2018 May; 27(5):581-593. PubMed ID: 29098467
[TBL] [Abstract][Full Text] [Related]
7. A randomized placebo-controlled trial of electroencephalographic (EEG) neurofeedback in children with attention-deficit/hyperactivity disorder.
van Dongen-Boomsma M; Vollebregt MA; Slaats-Willemse D; Buitelaar JK
J Clin Psychiatry; 2013 Aug; 74(8):821-7. PubMed ID: 24021501
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of neurofeedback versus medication for attention-deficit/hyperactivity disorder.
Sudnawa KK; Chirdkiatgumchai V; Ruangdaraganon N; Khongkhatithum C; Udomsubpayakul U; Jirayucharoensak S; Israsena P
Pediatr Int; 2018 Sep; 60(9):828-834. PubMed ID: 29931709
[TBL] [Abstract][Full Text] [Related]
9. Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: a 6-month follow-up.
Duric NS; Assmus J; Gundersen D; Duric Golos A; Elgen IB
Nord J Psychiatry; 2017 Jul; 71(5):386-394. PubMed ID: 28345387
[TBL] [Abstract][Full Text] [Related]
10. Neurofeedback and standard pharmacological intervention in ADHD: a randomized controlled trial with six-month follow-up.
Meisel V; Servera M; Garcia-Banda G; Cardo E; Moreno I
Biol Psychol; 2013 Sep; 94(1):12-21. PubMed ID: 23665196
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of theta/beta neurofeedback on EEG power spectra in children with attention deficit hyperactivity disorder.
Janssen TWP; Geladé K; Bink M; van Mourik R; Twisk JWR; Maras A; Oosterlaan J
Clin Neurophysiol; 2020 Jun; 131(6):1332-1341. PubMed ID: 32304847
[TBL] [Abstract][Full Text] [Related]
12. Learning curves of theta/beta neurofeedback in children with ADHD.
Janssen TWP; Bink M; Weeda WD; Geladé K; van Mourik R; Maras A; Oosterlaan J
Eur Child Adolesc Psychiatry; 2017 May; 26(5):573-582. PubMed ID: 27866283
[TBL] [Abstract][Full Text] [Related]
13. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
[TBL] [Abstract][Full Text] [Related]
14. EEG Neurofeedback Training in Children With Attention Deficit/Hyperactivity Disorder: A Cognitive and Behavioral Outcome Study.
Shereena EA; Gupta RK; Bennett CN; Sagar KJV; Rajeswaran J
Clin EEG Neurosci; 2019 Jul; 50(4):242-255. PubMed ID: 30453757
[TBL] [Abstract][Full Text] [Related]
15. Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial.
Purper-Ouakil D; Blasco-Fontecilla H; Ros T; Acquaviva E; Banaschewski T; Baumeister S; Bousquet E; Bussalb A; Delhaye M; Delorme R; Drechsler R; Goujon A; Häge A; Kaiser A; Mayaud L; Mechler K; Menache C; Revol O; Tagwerker F; Walitza S; Werling AM; Bioulac S; Brandeis D
J Child Psychol Psychiatry; 2022 Feb; 63(2):187-198. PubMed ID: 34165190
[TBL] [Abstract][Full Text] [Related]
16. Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
Philipsen A; Jans T; Graf E; Matthies S; Borel P; Colla M; Gentschow L; Langner D; Jacob C; Groß-Lesch S; Sobanski E; Alm B; Schumacher-Stien M; Roesler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Heinrich V; Huss M; Kornmann C; Bürger A; Perlov E; Ihorst G; Schlander M; Berger M; Tebartz van Elst L;
JAMA Psychiatry; 2015 Dec; 72(12):1199-210. PubMed ID: 26536057
[TBL] [Abstract][Full Text] [Related]
17. Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD.
Bioulac S; Purper-Ouakil D; Ros T; Blasco-Fontecilla H; Prats M; Mayaud L; Brandeis D
BMC Psychiatry; 2019 Aug; 19(1):237. PubMed ID: 31370811
[TBL] [Abstract][Full Text] [Related]
18. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
Simonoff E; Taylor E; Baird G; Bernard S; Chadwick O; Liang H; Whitwell S; Riemer K; Sharma K; Sharma SP; Wood N; Kelly J; Golaszewski A; Kennedy J; Rodney L; West N; Walwyn R; Jichi F
J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of methylphenidate and behavioural parent training for children aged 3-5 years with attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled, and sham behavioural parent training-controlled trial.
Sugaya LS; Salum GA; de Sousa Gurgel W; de Morais EM; Del Prette G; Pilatti CD; Dalmaso BB; Leibenluft E; Rohde LA; Polanczyk GV
Lancet Child Adolesc Health; 2022 Dec; 6(12):845-856. PubMed ID: 36306807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
